Olverembatinib in chronic myeloid leukemia: is less actually better?
Not available.
Saved in:
| Main Authors: | Maria Agustina Perusini, Dennis Dong Hwan Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-06-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/12124 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimizing olverembatinib dose in chronic phase chronic myeloid leukemia
by: Xiaoshuai Zhang, et al.
Published: (2025-04-01) -
Chronic myeloid leukemia in India
by: John M Goldman
Published: (2013-01-01) -
Retinal infiltration by chronic myeloid leukemia
by: Maïlys Charmasson, et al.
Published: (2025-03-01) -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2014-01-01) -
Less Acid + Less Bleeding = Better Outcomes and more Money!
by: Robert Enns
Published: (2004-01-01)